The company have significantly improved this development of a innovative solution for ATTR-CM, employing the compound. Initial trial information suggests promising outcomes for patients diagnosed by this debilitating https://bridgebio464573.canariblogs.com/firm-advances-cardiac-amyloidosis-management-using-the-therapy-57100639